These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 6460947)

  • 1. A double-blind clinical trial of isoniazid in Huntington disease.
    Perry TL; Wright JM; Hansen S; Thomas SM; Allan BM; Baird PA; Diewold PA
    Neurology; 1982 Apr; 32(4):354-8. PubMed ID: 6460947
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Isoniazid-induced elevation of CSF GABA levels and effects on chorea in Huntington's disease.
    Manyam BV; Katz L; Hare TA; Kaniefski K; Tremblay RD
    Ann Neurol; 1981 Jul; 10(1):35-7. PubMed ID: 6455963
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Isoniazid therapy of Huntington disease.
    Perry TL; Wright JM; Hansen S; MacLeod PM
    Neurology; 1979 Mar; 29(3):370-5. PubMed ID: 156313
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A controlled trial of isoniazid therapy for action tremor in multiple sclerosis.
    Bozek CB; Kastrukoff LF; Wright JM; Perry TL; Larsen TA
    J Neurol; 1987 Jan; 234(1):36-9. PubMed ID: 3546605
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Isoniazid-induced alteration of CSF neurotransmitter amino acids in Huntington's disease.
    Manyam BV; Ferraro TN; Hare TA
    Brain Res; 1987 Apr; 408(1-2):125-30. PubMed ID: 2885064
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Failure of aminooxyacetic acid therapy in Huntington disease.
    Perry TL; Wright JM; Hansen S; Allan BM; Baird PA; MacLeod PM
    Neurology; 1980 Jul; 30(7 Pt 1):772-5. PubMed ID: 6446691
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Brain amino compounds in a Huntington's disease patient on isoniazid therapy.
    Perry TL; Wall RA; Hansen S
    Neurology; 1985 May; 35(5):755-8. PubMed ID: 3157886
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of isoniazid on cerebrospinal fluid and plasma GABA levels in Huntington's disease.
    Manyam NV; Hare TA; Katz L
    Life Sci; 1980 Apr; 26(16):1303-8. PubMed ID: 6446011
    [No Abstract]   [Full Text] [Related]  

  • 9. Failure of isoniazid therapy in Huntington disease.
    McLean DR
    Neurology; 1982 Oct; 32(10):1189-91. PubMed ID: 6214730
    [No Abstract]   [Full Text] [Related]  

  • 10. Elevation of gamma-aminobutyric acid in human brain may increase dopaminergic neuronal function.
    Perry TL; Ito M; Jones K; Hansen S
    Neurosci Lett; 1984 Sep; 50(1-3):67-71. PubMed ID: 6238245
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cerebrospinal fluid acetylcholinesterase and choline measurements in Huntington's disease.
    Manyam BV; Giacobini E; Colliver JA
    J Neurol; 1990 Aug; 237(5):281-4. PubMed ID: 2146369
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Isoniazid-associated hepatitis and antiretroviral drugs during tuberculosis prophylaxis in hiv-infected adults in Botswana.
    Tedla Z; Nyirenda S; Peeler C; Agizew T; Sibanda T; Motsamai O; Vernon A; Wells CD; Samandari T
    Am J Respir Crit Care Med; 2010 Jul; 182(2):278-85. PubMed ID: 20378730
    [TBL] [Abstract][Full Text] [Related]  

  • 13. GABA and movement disorders.
    Marsden CD; Sheehy MP
    Adv Biochem Psychopharmacol; 1981; 30():225-34. PubMed ID: 6460427
    [No Abstract]   [Full Text] [Related]  

  • 14. Controlled trial of isoniazid therapy for severe postural cerebellar tremor in multiple sclerosis.
    Hallett M; Lindsey JW; Adelstein BD; Riley PO
    Neurology; 1985 Sep; 35(9):1374-7. PubMed ID: 3895037
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metabolomic analysis reveals novel isoniazid metabolites and hydrazones in human urine.
    Li F; Miao Y; Zhang L; Neuenswander SA; Douglas JT; Ma X
    Drug Metab Pharmacokinet; 2011; 26(6):569-76. PubMed ID: 21844656
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Randomised controlled trial of isoniazid preventive therapy in South African adults with advanced HIV disease.
    Mohammed A; Myer L; Ehrlich R; Wood R; Cilliers F; Maartens G
    Int J Tuberc Lung Dis; 2007 Oct; 11(10):1114-20. PubMed ID: 17945069
    [TBL] [Abstract][Full Text] [Related]  

  • 17. INH therapy: benefits versus risks.
    Smith DB
    Neurology; 1979 Oct; 29(10):1437-8. PubMed ID: 158144
    [No Abstract]   [Full Text] [Related]  

  • 18. Does isoniazid increase the hepatotoxicity of the combination prothionamide-dapsone? Isoprodian Study Group.
    Int J Lepr Other Mycobact Dis; 1992 Dec; 60(4):536-41. PubMed ID: 1299708
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Isoniazid preventive therapy in HIV-infected children on antiretroviral therapy: a pilot study.
    Gray DM; Workman LJ; Lombard CJ; Jennings T; Innes S; Grobbelaar CJ; Cotton MF; Zar HJ
    Int J Tuberc Lung Dis; 2014 Mar; 18(3):322-7. PubMed ID: 24670570
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Six-months isoniazid-rifampin therapy for pulmonary tuberculosis. Report of a United States Public Health Service Cooperative Trial.
    Snider DE; Long MW; Cross FS; Farer LS
    Am Rev Respir Dis; 1984 Apr; 129(4):573-9. PubMed ID: 6370060
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.